FDA Adverse Event Malfunction Summary report: N

BD PROTECTOR P50

MDR report key: 9662093 · Received February 3, 2020

Report

Report Number
3003152976-2020-00033
Event Type
Malfunction
Date Received
February 3, 2020
Date of Event
January 13, 2020
Report Date
March 26, 2020
Manufacturer
BECTON DICKINSON, S.A.
Product Code
ONB
UDI-DI
30382905151058
PMA / PMN Number
K123213
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TU
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION: ONE PHOTO SAMPLE AND TWO UNUSED PROTECTOR SAMPLES WERE PROVIDED TO OUR QUALITY TEAM FOR INVESTIGATION. UPON VISUALLY INSPECTING THE PHOTO, A GREY PARTICLE INSIDE THE VIAL CAN BE OBSERVED. WITHOUT THE ACTUAL SAMPLE TO EVALUATE, WE CANNOT VERIFY THE ORIGIN OF THE PARTICLE. THE UNUSED SAMPLES WERE EVALUATED, NO ISSUES WERE IDENTIFIED DURING THE VISUAL INSPECTION. A DEVICE HISTORY REVIEW WAS PERFORMED FOR LOT 1909138, NO DEVIATIONS OR NON-CONFORMANCES WERE IDENTIFIED DURING THE MANUFACTURING PROCESS THAT COULD HAVE CONTRIBUTED TO THESE ISSUES. FRAGMENTATION TESTING IS PERFORMED DURING MANUFACTURING TO EVALUATE ANY PARTICULATES GENERATED AFTER TEN ACTIVATIONS. TESTING RESULTS WERE REVIEWED FOR THE REPORTED LOT AND RESULTS WERE FOUND TO BE ACCEPTABLE. TWO ADDITIONAL RETAINED SAMPLES ALONG WITH THE TWO UNUSED PROTECTORS RETURNED OF LOT 1909138 WERE USED FOR ADDITIONAL EVALUATION. FUNCTIONAL TESTING WAS PERFORMED, PENETRATING THE PROTECTOR WITH A SAMPLE INJECTOR TEN TIMES. IN ALL CASES THE PRODUCT FUNCTIONED AS INTENDED AND NO CORING WAS IDENTIFIED. WHILE PHASEAL NEEDLES ARE DESIGNED TO REDUCE CORING, THERE ARE SEVERAL FACTORS THAT MAY IMPACT CORING TENDENCY. CORING FROM THE MEMBRANE MAY OCCUR DUE TO FRAGMENTATION CAUSED BY MULTIPLE INJECTIONS OR EXCESSIVE WELDING OF THE MEMBRANE. CORING OF THE RUBBER STOPPER MAY RESULT DEPENDING ON THE STOPPER QUALITY, THE DESIGN AND DIMENSIONS OF THE NEEDLES USED, OR IF A POOR CONNECTION OF THE PROTECTOR OCCURS. BASED ON THE QUALITY TEAM'S INVESTIGATION, WE ARE NOT ABLE TO IDENTIFY A DEFINITIVE ROOT CAUSE RELATED TO OUR MANUFACTURING PROCESS AT THIS TIME.

Description of Event or Problem · 0

IT HAS BEEN REPORTED THAT THE BD¿ PROTECTOR P50 HAS BEEN FOUND EXPERIENCING CORING DURING USE. THE FOLLOWING HAS BEEN PROVIDED BY THE INITIAL REPORTER: RUBBER HAS FALLEN DURING THE ATTACHMENT OF AN UNDILUTED GEMKO DRUG. THEY MEAN WITH ¿RUBBER¿ AS A TOP OF THE VIAL. GEMKO 1000MG / KOÇAK FARMA / LOT: 1964932. PER REP: THAT PROTECTOR IS ASSEMBLED ONTO THE VIAL MANUALLY.

Additional Manufacturer Narrative · 1

A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED, BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT HAS BEEN REPORTED THAT THE BD¿ PROTECTOR P50 HAS BEEN FOUND EXPERIENCING CORING DURING USE. THE FOLLOWING HAS BEEN PROVIDED BY THE INITIAL REPORTER: RUBBER HAS FALLEN DURING THE ATTACHMENT OF AN UNDILUTED GEMKO DRUG. THEY MEAN WITH ¿RUBBER¿ AS A TOP OF THE VIAL. GEMKO 1000 MG / KOÇAK FARMA / LOT: 1964932. PER REP: THAT PROTECTOR IS ASSEMBLED ONTO THE VIAL MANUALLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
126120 BD PROTECTOR P50 INTRAVASCULAR ADMINISTRATION SET ONB BECTON DICKINSON, S.A. 515105 1909138 30382905151058

Patients

Seq Age Sex Outcome Treatment
1 Other